Edition:
United Kingdom

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

6.55USD
17 Aug 2018
Change (% chg)

$-0.94 (-12.60%)
Prev Close
$7.50
Open
$6.71
Day's High
$6.93
Day's Low
$6.49
Volume
1,507,361
Avg. Vol
185,288
52-wk High
$8.08
52-wk Low
$1.86

Latest Key Developments (Source: Significant Developments)

Amyris Announces Secondary Offering Of 7.65 Mln Shares Priced At $6.25 Per Share
Friday, 17 Aug 2018 

Aug 17 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES PRICING OF SECONDARY OFFERING.SAYS SECONDARY OFFERING OF 7.65 MILLION SHARES PRICED AT $6.25PER SHARE.AMYRIS ANNOUNCES PRICING OF SECONDARY OFFERING.  Full Article

Amyris Announces Non-Dilutive $36 Mln Term Loan
Monday, 2 Jul 2018 

July 2 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES NON-DILUTIVE $36 MILLION TERM LOAN TO PAY OFF STEGODON AND OTHER SHORT-TERM DEBT MATURITIES.AMYRIS INC - CASH FROM TERM LOAN WILL BE USED TO PAY OFF COMPANY'S STEGODON AND OTHER SHORT-TERM DEBT MATURITIES.AMYRIS INC - TERM LOAN ALSO INCLUDES ADDITIONAL $35 MILLION ACCORDION CREDIT FACILITY WITH OPTION FOR FINANCING CONSTRUCTION OF PRODUCTION FACILITY.  Full Article

Amyris Inc Files For Non-Timely 10-Q - SEC Filing
Wednesday, 16 May 2018 

May 16 (Reuters) - Amyris Inc ::AMYRIS INC FILES FOR NON-TIMELY 10-Q - SEC FILING.  Full Article

Amyris posts Q3 GAAP loss of $1.14 per share
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Amyris Inc :Amyris reports another strong quarter of product sales growth and expects strong finish for 2017.Q3 GAAP loss per share $1.14.Q3 revenue $24.2 million versus $26.5 million.Qtrly non-GAAP basic loss per share $‍0.81​.  Full Article

Amyris says collaboration with pharmaceutical company for biosynthetic drug discovery
Friday, 28 Oct 2016 

Amyris Inc :Amyris inc -collaboration with pharmaceutical company for biosynthetic drug discovery.  Full Article

Amyris agrees to collaborate with leading global food ingredients and nutraceuticals partner
Thursday, 13 Oct 2016 

Amyris Inc : Amyris agrees to collaboration terms with leading global food ingredients and nutraceuticals partner . Amyris Inc - expects to receive cash representing a short-term collaboration investment of $10 million .Amyris inc - expects to receive an equity investment of up to $20 million at $1.40 per share, $100 million in annual revenue starting in 2017.  Full Article

Amyris expanded its strategic partnership with a "global nutraceuticals market leader"
Friday, 30 Sep 2016 

Amyris Inc : Expanded its strategic partnership with a "global nutraceuticals market leader" . New agreement includes addition of a new nutraceutical target, a credit line of up to $25 million with a 5-year maturity . Says anticipated revenues from expanded partnership are expected to average over $70 million annually beyond 2017 .New agreement includes an option for a $5-million strategic investment.  Full Article

BRIEF-Amyris Inc Files For Non-Timely 10-K With U.S. SEC

* AMYRIS INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2H66fh4) Further company coverage: